AAAAAA

   
Results: 1-9 |
Results: 9
Telomerase inhibitors: possible consequences in cancer therapy
Authors: Guittat, L Alberti, P Mergny, JL Riou, JF Teulade-Fichou, MP Mailliet, P
Citation: L. Guittat et al., Telomerase inhibitors: possible consequences in cancer therapy, M S-MED SCI, 17(10), 2001, pp. 1076-1081
Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes
Authors: Koeppel, F Riou, JF Laoui, A Mailliet, P Arimondo, PB Labit, D Petitgenet, O Helene, C Mergny, JL
Citation: F. Koeppel et al., Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes, NUCL ACID R, 29(5), 2001, pp. 1087-1096
Synthesis of oxa-bridged analogues of farnesyltransferase inhibitor RPR 115135
Authors: Martin, C Mailliet, P Maddaluno, J
Citation: C. Martin et al., Synthesis of oxa-bridged analogues of farnesyltransferase inhibitor RPR 115135, J ORG CHEM, 66(11), 2001, pp. 3797-3805
From random screening of chemical libraries to the optimization of FPP-Competitive inhibitors of farnesyltransferase
Authors: Mailliet, P Laoui, A Bourzat, JD Capet, M Cheve, M Commercon, A Dereu, N LeBrun, A Martin, JP Peyronel, JF Salagnad, C Thompson, F Zucco, M Guitton, JD Pantel, G Bissery, MC Brealey, C Lavayre, J Lelievre, Y Riou, JF Vrignaud, P Duchesne, M Lavelle, F
Citation: P. Mailliet et al., From random screening of chemical libraries to the optimization of FPP-Competitive inhibitors of farnesyltransferase, CANC DRUG, 8, 2001, pp. 115-144
A diastereoselective switch in the access to isobenzofuran-derived alpha-selenoesters
Authors: Martin, C Mailliet, P Maddaluno, J
Citation: C. Martin et al., A diastereoselective switch in the access to isobenzofuran-derived alpha-selenoesters, ORG LETT, 2(7), 2000, pp. 923-925
Telomerase: a therapeutic target for the third millennium?
Authors: Lavelle, F Riou, JF Laoui, A Mailliet, P
Citation: F. Lavelle et al., Telomerase: a therapeutic target for the third millennium?, CR R ONC H, 34(2), 2000, pp. 111-126
Multivariate data analysis using D-optimal designs, partial least squares,and response surface modeling: A directional approach for the analysis of farnesyltransferase inhibitors
Authors: Giraud, E Luttmann, C Lavelle, F Riou, JF Mailliet, P Laoui, A
Citation: E. Giraud et al., Multivariate data analysis using D-optimal designs, partial least squares,and response surface modeling: A directional approach for the analysis of farnesyltransferase inhibitors, J MED CHEM, 43(9), 2000, pp. 1807-1816
The development of telomerase inhibitors: the G-quartet approach
Authors: Mergny, JL Mailliet, P Lavelle, F Riou, JF Laoui, A Helene, C
Citation: Jl. Mergny et al., The development of telomerase inhibitors: the G-quartet approach, ANTI-CAN DR, 14(4), 1999, pp. 327-339
`Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cells
Authors: Mazet, JL Padieu, M Osman, H Maume, G Mailliet, P Dereu, N Hamilton, AD Lavelle, F Sebti, SM Maume, BF
Citation: Jl. Mazet et al., `Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cells, FEBS LETTER, 460(2), 1999, pp. 235-240
Risultati: 1-9 |